Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
Israel, US condemn Belgium over planned prosecutions tied to Jewish circumcisions
(JTA) — A diplomatic spat erupted on Wednesday after Belgian prosecutors moved to charge two Jewish men tied to ritual circumcisions, prompting Israeli and U.S. officials to accuse Belgium of targeting Jews for practicing their faith.
Gideon Saar, Israel’s minister of foreign affairs, lit into the country in a post on X Wednesday morning, calling the indictments a “scarlet letter on Belgian society.”
“With this act Belgium joins a short and shameful list, together with Ireland, of countries that use criminal law to prosecute Jews for practicing Judaism,” Saar wrote, later calling circumcision a “cornerstone of Jewish faith” and urging the Belgian government to “act immediately and to find a solution.”
Saar’s condemnation was quickly joined by the U.S. ambassador to Belgium, Bill White, who had previously called on Belgium to drop the “ridiculous and antisemitic” investigation of mohels in February.
“This is a shameful stain on Belgium,” White wrote in a post on X. “The prosecution of these religious figures (mohels), one of whom is American, is WRONG and won’t be tolerated. Belgium will be thought of now as anti Semitic by world. Until this is resolved – there is no way around it.”
White, a President Donald Trump appointee who faced criticism for amplifying social media posts by a far-right Belgian political activist convicted of racism and Holocaust denial, added that the “Trump Administration condemns this judicial action” and called on the Belgian government to “work with the Jewish leaders and communities to find a certification solution immediately.”
The condemnation by White and Saar comes after the Antwerp Public Prosecutor’s Office announced that it intends to prosecute two Jewish men on charges related to performing circumcisions, a practice that is required by law to be performed by licensed medical professionals in Belgium.
Last year, Belgian authorities raided multiple sites, including two in Antwerp’s Jewish Quarter, at the beginning of an investigation into illegal circumcisions. Investigators also requested lists of children who had recently been circumcised, according to VRT NWS, the Flemish public broadcaster.
But the sharp criticism by the two leaders was later dismissed by Belgian Foreign Minister Maxime Prévot, who wrote in a reply to White’s post that it was “inappropriate to publicly criticize a country and tarnish its image simply because you disagree with judicial proceedings.”
“I recall that the proceedings in question were initiated by representatives of the Jewish community themselves,” Prévot continued. “To portray those as a country’s desire to undermine the religious freedom of Jews is defamatory. This freedom has never been called into question and never will be in our country. Our Constitution protects it. And it is not for an ambassador to dictate the government’s agenda.”
In response to Saar’s post, Prévot wrote, “Enough with these caricatures.”
“Since you yourself recently urged against conducting diplomacy via Twitter, I suggest that we discuss all these issues during a meeting in Israel at a time that suits you best, in order to put an end to any misinterpretations,” Prévot continued.
This article originally appeared on JTA.org.
The post Israel, US condemn Belgium over planned prosecutions tied to Jewish circumcisions appeared first on The Forward.
Uncategorized
Rutgers disinvites commencement speaker over tweet claiming Israelis ‘train dogs to sexually assault prisoners’
(JTA) — Administrators at Rutgers University have canceled a commencement speaker scheduled for next week, citing an “inflammatory claim” the speaker tweeted about Israel.
Rami Elghandour, a Rutgers alumnus and a producer of an Oscar-nominated docudrama about a Palestinian girl who died in Gaza, was set to deliver the speech at the university’s School of Engineering on May 15. But the university, New Jersey’s public flagship, rescinded the invitation on Wednesday.
The Associated Press was the first to report that Elghandour’s invitation had been rescinded and that the university said social media posts about Israel were the cause.
To the Jewish Telegraphic Agency, a university representative specifically cited an April 20 tweet by Elghandour that accuses Israel of genocide and says the Israelis are “running dungeons where they train dogs to sexually assault prisoners.”
The tweet was a response to a post from California Rep. Ro Khanna advocating for cutting U.S. aid to Israel, which was itself a response to a post by AIPAC, the pro-Israel lobby that has become a bogeyman in U.S. politics. The unsubstantiated claim that Israel trains dogs to assault prisoners has circulated widely in recent weeks among some pro-Palestinian activists.
“The Rutgers School of Engineering was recently informed that some graduating students would not attend their graduation ceremony due to concerns about the invited speaker’s social media posts, including one that shared an inflammatory claim,” Dory Devlin, a representative for Rutgers University, told JTA in an email. “After discussing these concerns with the speaker, the School of Engineering has rescinded the convocation speaker invitation to Rami Elghandour.”
Elghandour, who owns a biotech company and was an executive producer for the award-winning documentary “The Voice of Hind Rajab,” declined through a spokesperson to respond to a JTA request for comment. The spokesperson pointed to his statement on social media, where he disparaged the school’s decision.
“After a ‘few’ students complained about my selection as speaker because of my social media advocacy for Palestine, Rutgers has canceled my speech,” Elghandour wrote. “They decided that the feelings of a handful of students who said that my social media posts ‘opposed their beliefs’, were more important than the experience of the entire graduating class, the reputation of the school, the dignity and belonging of Arab and Muslim students, and the First Amendment.”
In addition to executive-producing “The Voice of Hind Rajab,” Elghandour was also a producer on the film “American Doctor,” about three physicians — including a Palestinian and a Jew — who traveled to Gaza to aid civilians there.
Rutgers University Hillel, the campus Jewish group that also engages students around Israel, did not immediately respond to a request for comment.
Rutgers settled a federal civil rights investigation into its handling of antisemitism in January 2025. It agreed to update its anti-discrimination policies as investigators were poised to find that the school did not protect Jewish students from antisemitism in the wake of the Oct. 7, 2023, attack on Israel and the subsequent war in Gaza.
The incident adds to a string of dustups over Israel at commencements this year and in the past. The University of Michigan’s president apologized after faculty senate chair Derek Peterson praised pro-Palestinian student protesters during his speech on Saturday; Elghandour shared several posts in defense of Peterson’s speech.
This article originally appeared on JTA.org.
The post Rutgers disinvites commencement speaker over tweet claiming Israelis ‘train dogs to sexually assault prisoners’ appeared first on The Forward.
Uncategorized
London Police Set Up Specialist Jewish Protection Team
A police officer stands at the scene, after a man was arrested following a stabbing incident in the Golders Green area, which is home to a large Jewish population, in London, Britain, April 29, 2026. Photo: REUTERS/Hannah McKay
British police are setting up a new team of 100 officers including counter terrorism specialists to help protect Jewish communities across London after a series of antisemitic attacks including the stabbing of two men.
The plan announced on Wednesday for a dedicated protection team comes as officers announced more arrests for antisemitism, including detaining a 35-year-old man on Saturday after rocks were thrown at an ambulance belonging to the Jewish community.
London‘s top police boss Mark Rowley said Jewish communities were facing “sustained threats” from hostile state actors as well as extreme right-wing groups, elements of the extreme left, and Islamist terrorists.
Detectives are examining whether the arson incidents have possible Iranian links, after British security officials warned that Iran was using criminal proxies to carry out hostile activity.
Since late March, there have been a number of high-profile arson attacks with four Jewish ambulances burned and synagogues targeted. Last week, two Jewish men were also stabbed. Both victims survived the attack.
Over the past four weeks, police said they had arrested around 50 people for antisemitic hate crimes and charged eight individuals. On top of that, 28 arrests have been made as part of investigations alongside counter terrorism policing for arson and other serious incidents.
“This new team will be primarily focused on protecting the Jewish community, which faces some of the highest levels of hate crime alongside significant terrorist and hostile state threats,” said a statement from London‘s Metropolitan Police force.
British Prime Minister Keir Starmer convened a meeting on Monday with business, health and cultural leaders aimed at trying to tackle antisemitism.